Revelation Biosciences, Inc. · NASDAQ:REVB
Revelation Biosciences, Inc. shareholders
As of Jun 30, 2026, 12 institutions reported holding Revelation Biosciences, Inc., 7.6% of its shares. Largest: Sabby Management, LLC, Citadel and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Revelation Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Sabby Management, LLC | 211K | 5.3% | +111K | Aug 14, 2026 |
| Citadel | 38,579 | 0.97% | new | Aug 14, 2026 |
| Geode Capital | 17,192 | 0.43% | −26,003 | Aug 12, 2026 |
| Hrt Financial LP | 16,978 | 0.43% | new | Aug 14, 2026 |
| Vanguard | 13,127 | 0.33% | no change | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 6,528 | 0.16% | +2,454 | Aug 11, 2026 |
| RBC | 747 | 0.02% | no change | Aug 14, 2026 |
| SBI Securities Co., Ltd. | 344 | <0.01% | no change | Jul 23, 2026 |
| Barclays | 168 | <0.01% | new | Aug 14, 2026 |
| BNP Paribas | 9 | <0.01% | no change | Aug 13, 2026 |